Free Trial
OTCMKTS:OTLC

Oncotelic Therapeutics (OTLC) Stock Price, News & Analysis

Oncotelic Therapeutics logo
$0.05 +0.00 (+3.04%)
As of 08/7/2025 11:40 AM Eastern

About Oncotelic Therapeutics Stock (OTCMKTS:OTLC)

Key Stats

Today's Range
$0.05
$0.05
50-Day Range
$0.04
$0.07
52-Week Range
$0.02
$0.07
Volume
2,500 shs
Average Volume
147,036 shs
Market Capitalization
$19.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OTLC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OTLC Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
Oncotelic Therapeutics, Inc. (OTLC) - Yahoo Finance
Oncotelic Therapeutics Inc (OTLC)
See More Headlines

OTLC Stock Analysis - Frequently Asked Questions

Oncotelic Therapeutics' stock was trading at $0.0350 on January 1st, 2025. Since then, OTLC stock has increased by 35.7% and is now trading at $0.0475.

Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC) posted its quarterly earnings data on Thursday, August, 19th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.02.

Shares of OTLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncotelic Therapeutics investors own include MariMed (MRMD), First Wave BioPharma (FWBI), DSS (DSS), Cemex (CX), CohBar (CWBR), ContraFect (CFRX) and Avid Bioservices (CDMO).

Company Calendar

Last Earnings
8/19/2021
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:OTLC
CIK
908259
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.52 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-14.16%
Return on Assets
-4.41%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
$70 thousand
Price / Sales
277.06
Cash Flow
$0.01 per share
Price / Cash Flow
8.98
Book Value
$0.02 per share
Price / Book
2.38

Miscellaneous

Outstanding Shares
408,292,000
Free Float
248,160,000
Market Cap
$19.39 million
Optionable
Not Optionable
Beta
-0.90
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:OTLC) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners